Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Operating Expenses: 2012-2024

Historic Operating Expenses for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to $647.4 million.

  • Ascendis Pharma A's Operating Expenses fell 33.85% to -$210.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.3 million, marking a year-over-year increase of 9.71%. This contributed to the annual value of $647.4 million for FY2024, which is 11.24% down from last year.
  • Ascendis Pharma A's Operating Expenses amounted to $647.4 million in FY2024, which was down 11.24% from $729.3 million recorded in FY2023.
  • Over the past 5 years, Ascendis Pharma A's Operating Expenses peaked at $729.3 million during FY2023, and registered a low of $395.6 million during FY2020.
  • In the last 3 years, Ascendis Pharma A's Operating Expenses had a median value of $647.4 million in 2024 and averaged $663.3 million.
  • As far as peak fluctuations go, Ascendis Pharma A's Operating Expenses soared by 5,562.74% in 2020, and later decreased by 11.24% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Operating Expenses (Yearly) stood at $395.6 million in 2020, then spiked by 36.07% to $538.3 million in 2021, then grew by 13.87% to $613.0 million in 2022, then grew by 18.98% to $729.3 million in 2023, then decreased by 11.24% to $647.4 million in 2024.